TPX2 promotes gastric cancer progression and angiogenesis via Wnt/β-catenin signaling
{{output}}
Background: Among gastric cancer (GC) cases, stomach adenocarcinoma (STAD) comprises the majority, exceeding 95%. GC develops stealthily and quickly; the majority of cases are detected at advanced or mid-stage, which adversely af... ...
